Clinical Trials
38
Active:34
Completed:1
Trial Phases
3 Phases
Phase 1:32
Phase 2:2
Phase 3:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (38 trials with phase data)• Click on a phase to view related trials
Phase 1
32 (84.2%)Phase 3
3 (7.9%)Phase 2
2 (5.3%)phase_1_2
1 (2.6%)No trials found
News
Solve Therapeutics Secures $120 Million to Advance Next-Generation ADC Platform for Solid Tumors
Solve Therapeutics raised $120 million in an oversubscribed financing round led by Yosemite to accelerate development of its clinical-stage ADC pipeline featuring proprietary CloakLink™ linker technology.